Trinity Biotech (TRIB) EPS (Weighted Average and Diluted) (2021 - 2022)
Trinity Biotech's (TRIB) quarterly EPS (Weighted Average and Diluted) came in at -$53421.1 in Q2 2022, down 505.47% year-on-year from $13175.0 in Q2 2021, and down 505.47% quarter-over-quarter from $13175.0 in Q2 2021.
Trinity Biotech (TRIB) EPS (Weighted Average and Diluted) (2021 - 2022) Analysis & Trends
Trinity Biotech has disclosed EPS (Weighted Average and Diluted) across 2 years of filings, most recently posting -$53421.1 for Q2 2022.
- EPS (Weighted Average and Diluted) for Q2 2022 came in at -$53421.1, down 505.47% year-over-year; the trailing twelve-month figure through Jun 2022 was -$53421.1 (down 505.47% YoY), and the FY2025 annual result was -$2.0, down 11.11% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$53421.1 for Q2 2022 at Trinity Biotech, down from $13175.0 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $13175.0 in Q2 2021 to a low of -$53421.1 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -53,421.05 |
| Jun 30, 2021 | 13,175.00 |